A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis
Clinical trial NCT03029455 · COMPLETED
Trial details
- NCT number
- NCT03029455
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-08-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.